Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
7.13
-1.08 (-13.15%)
At close: Jun 26, 2026, 4:00 PM EDT
7.36
+0.23 (3.29%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Unicycive Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Unicycive Therapeutics stock have an average target of 43.88, with a low estimate of 18 and a high estimate of 90. The average target predicts an increase of 515.43% from the current stock price of 7.13.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Unicycive Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 7 | 8 | 8 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $22 | Buy | Maintains | $22 | +208.56% | Jun 26, 2026 |
| Benchmark Co. | Benchmark Co. | Buy Maintains $15 → $18 | Buy | Maintains | $15 → $18 | +152.45% | Jun 2, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $90 | Buy | Maintains | $90 | +1,162.27% | Jun 2, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $60 | Buy | Reiterates | $60 | +741.51% | May 13, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $40 → $37 | Buy | Maintains | $40 → $37 | +418.93% | May 13, 2026 |
Financial Forecast
Revenue This Year
17.83M
Revenue Next Year
346.25M
from 17.83M
Increased by 1,841.85%
EPS This Year
-0.98
from -1.67
EPS Next Year
6.04
from -0.98
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 81.6M | 1.1B | |
| Avg | 17.8M | 346.2M | |
| Low | 4.0M | 93.0M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 6,284.5% | 250.7% |
| Avg | 1,841.8% | 60.9% |
| Low | 421.7% | -30.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.46 | 24.06 | |
| Avg | -0.98 | 6.04 | |
| Low | -1.61 | 1.18 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.